Cargando…
Equal Efficacy and Safety Profile in Elderly Patients with Hepatocellular Carcinoma Receiving Palliative Treatment
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) is the most common primary liver tumor and a leading cause of cancer-related death worldwide with an increasing incidence, especially in elderly people. However, as elderly patients are often characterized by other comorbidities and frailty, palliative...
Autores principales: | Fründt, Thorben W., Casar, Christian, von Felden, Johann, Schöler, Ulrike, Priebe, Maximilian, Kraczyk, Jenny, Ahrend, Hannes, Salamon, Johannes, Adam, Gerhard, Huber, Samuel, Lohse, Ansgar W., Wege, Henning, Schulze, Kornelius |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833746/ https://www.ncbi.nlm.nih.gov/pubmed/35159035 http://dx.doi.org/10.3390/cancers14030768 |
Ejemplares similares
-
Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
por: Fründt, Thorben, et al.
Publicado: (2022) -
Diagnostic and Prognostic Value of miR-16, miR-146a, miR-192 and miR-221 in Exosomes of Hepatocellular Carcinoma and Liver Cirrhosis Patients
por: Fründt, Thorben, et al.
Publicado: (2021) -
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
por: Krause, Jenny, et al.
Publicado: (2020) -
Elevated Aspartate Aminotransferase to Alanine Aminotransferase Ratio Predicts Poor Outcome in Hepatocellular Carcinoma
por: von Felden, Johann, et al.
Publicado: (2020) -
High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection
por: von Felden, Johann, et al.
Publicado: (2017)